Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Study Type: Interventional"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22MCRPC%22&type=Subject&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
/vufind/Search/Results?lookfor=%22MCRPC%22&type=Subject&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
Search /vufind/Search2/Results?lookfor=%22MCRPC%22&type=Subject&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
PubPharm (320)
1
Phase 3 Study of Pembrolizumab Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in mCRPC : A Phase 3, Randomized Open-label Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castrationresistant Prostate Cancer (mCRPC) Who are Unselected for Homologous Recombination Repair Defects and Have Failed Prior Treatment with One Next generation Hormonal Agent (NHA) and Chemotherapy (KEYLYNK-010) - Pembrolizumab+Olaparib vs Abiraterone Acetate or Enzalutamide in mCRPC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Phase 3 Study of Pembrolizumab Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in mCRPC : A Phase 3, Randomized Open-label Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castrationresistant Prostate Cancer (mCRPC) Who are Unselected for Homologous Recombination Repair Defects and Have Failed Prior Treatment with One Next generation Hormonal Agent (NHA) and Chemotherapy (KEYLYNK-010) - Pembrolizumab+Olaparib vs Abiraterone Acetate or Enzalutamide in mCRPC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Pharmacokinetic study of enzalutamide and cabazitaxel combination therapy : Pharmacokinetic study of enzalutamide and cabazitaxel combination therapy in metastatic castrate-resistant prostate cancer (mCRPC) patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Pharmacokinetic study of enzalutamide and cabazitaxel combination therapy : Pharmacokinetic study of enzalutamide and cabazitaxel combination therapy in metastatic castrate-resistant prostate cancer (mCRPC) patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
An international study of 177LU-PSMA-617 in the treatment of patients with progressive metastatic castration-resistant prostate cancer : VISION: An international, prospective, open label, multicenter, randomized Phase 3 study of 177LU-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) - VISION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
An international study of 177LU-PSMA-617 in the treatment of patients with progressive metastatic castration-resistant prostate cancer : VISION: An international, prospective, open label, multicenter, randomized Phase 3 study of 177LU-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) - VISION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
CABAzitaxel with or without prednisone in patients with metastatic CAstration REsistant prostate cancer (mCRPC) progressed during or after a previous docetaxel-based chemotherapy: a multi-center, prospective, two-arm, open label, non inferiority phase II study. : CABAzitaxel with or without prednisone in patients with metastatic CAstration REsistant prostate cancer (mCRPC) progressed during or after a previous docetaxel-based chemotherapy: a multi-center, prospective, two-arm, open label, non inferiority phase II study. - CABACARE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer. : Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365) - Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in mCRPC (KEYNOTE-365)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
An international study of 177LU-PSMA-617 in the treatment of patients with progressive metastatic castration-resistant prostate cancer : VISION: An international, prospective, open label, multicenter, randomized Phase 3 study of 177LU-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) - VISION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
An international study of 177LU-PSMA-617 in the treatment of patients with progressive metastatic castration-resistant prostate cancer : VISION: An international, prospective, open label, multicenter, randomized Phase 3 study of 177LU-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) - VISION
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Study Type: Interventional
Medienart
320
Aufsätze
320
E-Artikel
320
E-Ressourcen
Zeitschriftentitel
306
WHO International Clinical Trials Registry Plat...
14
ClinicalTrials.gov
Thema
320
610
Study Type: Interventional
172
Recruitment Status: Authorised-recruitment may ...
123
Recruitment Status: Not yet recruiting
109
Phase: Phase 3
74
Phase: Phase 2
61
Phase: Phase 1
46
Phase: Phase 4
32
Medical Condition: Metastatic Castration-Resist...
20
Medical Condition: Metastatic castration resist...
11
Prostatic Neoplasms
10
Medical Condition: PSMA-positive metastatic cas...
10
Recruitment Status: Completed
9
Recruitment Status: Recruiting
8
Medical Condition: Metastatic Castrate Sensitiv...
8
Medical Condition: Metastatic Castration resist...
8
Medical Condition: Metastatic Castration-Resist...
8
Medical Condition: Metastatic Castration-Resist...
8
Medical Condition: Metastatic Castration-resist...
8
Medical Condition: metastatic castration-resist...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
213
2020-
107
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
320
Englisch
Haven't found what you're looking for?
Wird geladen...